HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nancy L Monson Selected Research
Nancy L Monson Research Topics
Disease
17
Multiple Sclerosis
10/2023 - 02/2005
7
Relapsing-Remitting Multiple Sclerosis
09/2017 - 10/2010
5
Autoimmune Diseases (Autoimmune Disease)
10/2023 - 04/2008
4
Neuroinflammatory Diseases
01/2021 - 05/2015
3
Cognitive Dysfunction
01/2019 - 12/2015
3
Infections
01/2018 - 10/2006
3
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2016 - 02/2011
3
Progressive Multifocal Leukoencephalopathy
01/2012 - 10/2006
2
Chronic Progressive Multiple Sclerosis
01/2021 - 02/2005
2
Encephalitis (Encephalitis, Rasmussen)
09/2017 - 01/2014
2
Neuromyelitis Optica (Devic's Disease)
11/2016 - 09/2015
2
Autoimmune Diseases of the Nervous System
11/2016 - 03/2016
2
Stroke (Strokes)
05/2015 - 01/2014
1
COVID-19
04/2022
1
Pain (Aches)
01/2022
1
Systemic Scleroderma (Systemic Sclerosis)
01/2022
1
Localized Scleroderma (Morphea)
01/2022
1
Disease Progression
01/2021
1
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
09/2017
1
Neoplasms (Cancer)
09/2017
1
Nervous System Diseases (Neurological Disorders)
11/2016
1
Rheumatoid Arthritis
06/2015
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2015
1
Infarction (Infarctions)
05/2015
1
Inflammation (Inflammations)
05/2015
1
Hypersensitivity (Allergy)
02/2011
1
Headache (Headaches)
07/2007
1
Opportunistic Infections (Opportunistic Infection)
02/2007
1
Demyelinating Diseases (Demyelinating Disease)
10/2006
Drug/Important Bio-Agent (IBA)
6
Antigens
IBA
10/2023 - 05/2007
5
Antibodies
IBA
10/2023 - 01/2007
5
Natalizumab (Tysabri)
FDA Link
01/2012 - 05/2006
4
Cytokines
IBA
01/2021 - 04/2008
3
Interleukin-10 (Interleukin 10)
IBA
01/2021 - 08/2012
3
Interleukin-6 (Interleukin 6)
IBA
01/2021 - 08/2012
3
Amyloid (Amyloid Fibrils)
IBA
01/2019 - 12/2015
3
Rituximab (Mabthera)
FDA Link
09/2017 - 02/2005
3
inebilizumab
IBA
11/2016 - 11/2014
2
ocrelizumab
IBA
08/2023 - 01/2021
2
Autoantigens
IBA
01/2022 - 04/2008
2
Autoantibodies
IBA
01/2022 - 02/2016
2
Myelin Basic Protein
IBA
01/2022 - 10/2010
2
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
09/2017 - 05/2015
2
Codon (Codons)
IBA
09/2017 - 02/2009
1
Pancreatic Elastase (Elastase)
IBA
04/2022
1
Interleukin-8 (Interleukin 8)
IBA
04/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Epitopes
IBA
01/2022
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2021
1
Amyloid beta-Peptides
IBA
01/2019
1
Immunoglobulin G (IgG)
IBA
09/2017
1
Uric Acid (Urate)
IBA
03/2016
1
Indicators and Reagents (Reagents)
IBA
09/2015
1
Peptides (Polypeptides)
IBA
05/2015
1
Proteins (Proteins, Gene)
FDA Link
05/2015
1
Glatiramer Acetate (Copaxone)
FDA Link
11/2014
1
Percoll
IBA
01/2014
1
Chemokines
IBA
01/2014
1
Interleukin-17 (Interleukin 17)
IBA
02/2011
1
Myelin-Oligodendrocyte Glycoprotein
IBA
10/2010
1
Prion Proteins
IBA
02/2009
1
Immunoglobulins (Immunoglobulin)
IBA
05/2007
1
Immunoglobulin Fab Fragments
IBA
05/2007
1
Integrins
IBA
10/2006
1
Integrin alpha4beta1 (VLA-4)
IBA
10/2006
1
Monoclonal Antibodies
IBA
10/2006
Therapy/Procedure
6
Therapeutics
12/2016 - 02/2007
1
Critical Care (Surgical Intensive Care)
01/2018
1
Plasma Exchange
09/2017